AMLX - Amylyx Pharmaceuticals Inc
IEX Last Trade
2.21
0.090 4.072%
Share volume: 414,060
Last Updated: Fri 30 Aug 2024 09:59:39 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$2.12
0.09
4.25%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-11 | 2022-11-10 | 2023-03-13 | 2023-05-11 | 2023-08-10 | 2023-11-09 | 2024-02-22 | 2024-05-09 | |
Cash flow financing | -828.000 K | 0.000 | 232.162 M | 1.040 M | 1.384 M | 889.000 K | 230.000 K | 131.000 K | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash flow | -46.462 M | -43.078 M | -49.697 M | -5.072 M | 8.609 M | -5.169 M | 13.551 M | -489.000 K | |
Net income | -54.067 M | -53.756 M | -42.704 M | 1.573 M | 22.074 M | 20.893 M | 4.731 M | -118.793 M | |
Depreciation | 105.000 K | 165.000 K | 182.000 K | 204.000 K | 281.000 K | 302.000 K | 301.000 K | 315.000 K | |
Changes in inventories | 0.000 | 563.000 K | 9.769 M | 13.075 M | 24.858 M | 32.374 M | 38.323 M | 0.000 | |
Changes in receivables | 0.000 | 137.000 K | 15.306 M | 17.555 M | 33.473 M | 29.353 M | 40.050 M | 20.351 M | |
Investing Cashflow | 4.462 M | 84.041 M | -228.180 M | 55.994 M | 123.222 M | -108.088 M | 20.925 M | 819.000 K | |
Net Borrowings | -209.065 M | -164.741 M | -350.781 M | -352.636 M | -363.776 M | -367.615 M | -382.056 M | -386.489 M | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | -1.105 M | -459.000 K | -620.000 K | -250.000 K | -278.000 K | -357.000 K | -356.000 K | -67.000 K | |
Cash Change | 206.681 M | 162.593 M | 346.945 M | 345.674 M | 357.276 M | 355.045 M | 371.362 M | 373.293 M |